378 related articles for article (PubMed ID: 19665604)
1. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
[TBL] [Abstract][Full Text] [Related]
2. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.
Ryan M; Gothefors L; Storsaeter J; Mills KH
Dev Biol Stand; 1997; 89():297-305. PubMed ID: 9272363
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the infant immune responses by the first pertussis vaccine administrations.
Mascart F; Hainaut M; Peltier A; Verscheure V; Levy J; Locht C
Vaccine; 2007 Jan; 25(2):391-8. PubMed ID: 17116347
[TBL] [Abstract][Full Text] [Related]
4. The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Xing D; Walker KB
Cell Immunol; 2004 Jan; 227(1):51-8. PubMed ID: 15051514
[TBL] [Abstract][Full Text] [Related]
5. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
6. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
[TBL] [Abstract][Full Text] [Related]
7. Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose.
Vermeulen F; Dirix V; Verscheure V; Damis E; Vermeylen D; Locht C; Mascart F
Vaccine; 2013 Apr; 31(15):1981-6. PubMed ID: 23429006
[TBL] [Abstract][Full Text] [Related]
8. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
10. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
Lavigne MV; Castro M; Andino J; Manghi M
Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to pertussis vaccines and disease.
Edwards KM; Berbers GA
J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
[TBL] [Abstract][Full Text] [Related]
13. Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.
Edelman KJ; He Q; Makinen JP; Haanpera MS; Tran Minh NN; Schuerman L; Wolter J; Mertsola JA
Clin Infect Dis; 2004 Jul; 39(2):179-85. PubMed ID: 15307026
[TBL] [Abstract][Full Text] [Related]
14. Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients?
Cassone A; Mastrantonio P; Ausiello CM
J Infect Dis; 2000 Nov; 182(5):1575-7. PubMed ID: 11023488
[No Abstract] [Full Text] [Related]
15. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.
White OJ; Rowe J; Richmond P; Marshall H; McIntyre P; Wood N; Holt PG
Vaccine; 2010 Mar; 28(14):2648-52. PubMed ID: 20096390
[TBL] [Abstract][Full Text] [Related]
16. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
[TBL] [Abstract][Full Text] [Related]
17. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
[TBL] [Abstract][Full Text] [Related]
18. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
David S; van Furth R; Mooi FR
Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
[TBL] [Abstract][Full Text] [Related]
19. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
20. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
